Detalhe da pesquisa
1.
Anti-KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria.
Allergy
; 78(5): 1269-1279, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36385701
2.
Anti-KIT monoclonal antibody CDX-0159 induces profound and durable mast cell suppression in a healthy volunteer study.
Allergy
; 77(8): 2393-2403, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35184297
3.
Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C.
Hepatology
; 62(2): 409-16, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25251156
4.
Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer.
Cancers (Basel)
; 14(10)2022 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35625959
5.
Clinical observation of liver chemistry abnormalities in asthmatics.
Curr Drug Saf
; 4(3): 173-80, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19534645